Sequencing of the genome of the SARS-CoV-2 virus for the monitoring and management of the Covid-19 epidemic in Andalusia and the rapid generation of prognostic biomarkers and response to treatment

Grant number: COVID-0012-2020

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $113,300
  • Funder

    Junta de Andalucia
  • Principal Investigator

    Joaquín Dopazo, Nicola Lorusso, Francisco Javier García León, José María Navarro Mari, Federico García García
  • Research Location

    Spain
  • Lead Research Institution

    Fundación Promoción Social
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

A Genomic Surveillance Circuit for Emerging Viral Pathogens.

The integrated genomic surveillance system of Andalusia (SIEGA) provides a One Health regional resource connected with the clinic.

Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments.

Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia.

Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival.

Highly accurate whole-genome imputation of SARS-CoV-2 from partial or low-quality sequences.